In the specialized field of biochemical research, the study of myelin-associated prot MOG Protein 35-55, MOG Peptide Fragment human eins has become a cornerstone for understanding structural integrity within the central nervous system. As a dedicated enthusiast of peptid MOG Peptides, Myelin Oligodendrocyte Glycoprotein e synthesis and structural biology, I have spent significant time analyzing the human MOG peptide, specifically the widely utilized MOG (35-55) human sequence (MEVGWYRPPFSRVVHLYRNGK). My interest lies in how these fragments function as tools for exploring complex biological pathways.
Understanding the Myelin Oligodendrocyte Glycoprotein (MOG)
The human MOG protein is a transmembrane protein primarily localized to the outermost surface of myelin sheaths. It is a minor component of the myelin sheath but plays a pivotal role in cell-cell communication and the overall maintenance of myelin architecture. In humans, this protein is encoded by the *MOG* gene, which consists of 8 exons. Because it is expressed on the oligodendrocyte cell surface, it serves as a critical focal point for research into how structural proteins interact within the central nervous system.
The Significance of MOG (35-55)
When researchers look for a standardized peptide for experimental models, they frequently select MOG (35-55), human. This specific fragment is a synthetic sequence corresponding to amino acid residues 35–55 of the extracellular domain.
One of the most common ways this material is used as an antigen/immunogen is to investigate immune responses in a laboratory setting. The application of MOG Protein (35-55) induces an autoantibody response that helps researchers model specific biological processes. It is essential to note that MOG (35-55), human is a component of CNS myelin, which makes it a highly relevant target for those studying the dynamics of the myelin sheath.
Comparative Analysis: Human vs. Mouse Variants
In my experience reviewing technical data, it is vital to distinguish between species-specific sequ by M Rodi·2024·Cited by 3—Our group is working on the development ofpeptide-based treatments for MS. The present work completes a cycle of preclinical testing (EAE → short-term testing Read more ences. For instance, human MOG 35–55 peptide differs from its murine counterpart (mMOG 35-55) due to MOG Peptide (human, bovine) (acetate) a single proline for serine substitution at position 42. This small change in the amino acid sequence can significantly alter how the peptide interacts with receptors, highlighting the precision required in peptide selection. Furthermore, researchers often utilize a Human MOG (1-125) Peptide Pool—a comprehensive set of 29 peptides—to gain a broader view of immunological interactions than a single fragment can provide.
Research Applications In MOG35–55peptide-induced EAE, B cells do not become activated or efficiently polarize proinflammatoryMOG-specific T cells, resulting in exacerbation of EAE Read more and Biomarkers
The study of MOG peptides extends beyond simple fragment analysis. For example, MOG expression in the brain can be used as a temporal biomarker for myelin development. By utilizing high-purity Myelin Oligodendrocyte Glycoprotein (MOG) peptide, investigators can perform T-cell assays and MHC binding studies with greater accuracy.
Another interesting area involves the MOG92–106 peptide, which has been analyzed for its structural role in demyelination-related epitopes. Additionally, the MOG peptide is used for blocking the activity of MOG antibody in specific assays to ensure specificity and reduce background interference.
Final Thoughts on Peptide Integrity
Whether one is working with MOG35–55 for structural studies or investigating the broader Myelin Oligodendrocyte Glycoprotein (MOG) 35-55 for its role in CNS research, the qualit MOG Protein 35-55is used as an antigen/immunogento induce anti-MOG antibodies to induce experimental diseases such as experimental autoimmune y of the peptide is paramount. As a user, I prioritize high-purity, synthetic fragments that are well-characterized. The structural complexity of this protein—a protein containing a single peptide of 29 amino a MOG (35-55) human - MEVGWYRPPFSRVVHLYRNGK cids followed by the mature domain—remains a fascinating subject for those of us dedicated to the nuances of protein chemistry and the exploration of mog peptides in controlled environments.
By maintaining rigorous standards in the handling and application of these fragments, we continue to deepen our understanding of the proteins that provide the structural framework for the central nervous system.